Metformin causes cancer cell death through downregulation of p53-dependent differentiated embryo chondrocyte 1

BACKGROUND: Metformin is the most commonly used first-line medicine for type II diabetes mellitus. Acting via AMP-activated protein kinase, it has been used for more than 60 years and has an outstanding safety record. Metformin also offers protection against cancer, but its precise mechanisms remain...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Biomed Sci
Huvudupphovsmän: Hsieh Li, Shu-Man, Liu, Shu-Ting, Chang, Yung-Lung, Ho, Ching-Liang, Huang, Shih-Ming
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2018
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6238313/
https://ncbi.nlm.nih.gov/pubmed/30442142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-018-0478-5
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk